To investigate changes in the serum concentration and renal expression of IL-1 and TNF-α cytokines in rats that received sevoflurane and glibenclamide prior to hemorrhage.
Introduction
Hemorrhagic shock produces multiple abnormalities in immunological functions, resulting in immunodeficiency and a subsequent increased susceptibility to sepsis 1 . Tissue hypoxia that occurs after hemorrhagic shock produces changes in cellular organic metabolism 2 , and induces the release of proinflammatory cytokines, such as interleukins one and six (IL-1 and IL-6) and tumor necrosis α factor (TNF-α), into the plasma. The excessive activation of inflammatory mediators after trauma/hemorrhagic shock leads to multiple organ dysfunction syndromes, a major cause of mortality in patients [3] [4] [5] . Ischemia/reperfusion process triggers macrophages and activated Küpffer cells release inflammatory cytokines
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. Glibenclamide, an anti-diabetic agent, is a K ATP channel antagonist with half-life of 4±1 hour [7] [8] [9] . Some experimental studies have shown a possible relationship between glibenclamide action on the K ATP channel and effects in the inflammatory process 10, 11 . A previous study from our laboratory has investigated the action of glibenclamide in the kidneys of rats anesthetized with sevoflurane that suffered 30% blood volume loss and hemorrhagic shock secondary to inadequate fluid replacement. 
Methods

Ethics Committee in Animal Experimentation of the
Botucatu Medical School, UNESP, approved the study that involved 20 adult Wistar rats, randomly distributed into two groups of 10 rats each, G1 and G2; all rats were anesthetized with sevoflurane and subjected to 30% blood volume loss. The rats in G2 received glibenclamide intravenously. The animals were housed in a transparent bell made of inert material and injected with 4% sevoflurane with a total flow of 1 L/min of O 2 and 1 L/ min of air from an Ohmeda vaporizer (USA). After the induction of anesthesia, the anesthetic concentration was decreased to 2.5%, and an appropriate mask non-rebreathing system was used; the rat maintained spontaneous breathing in the oxygen/air/sevoflurane mixture. The rectal temperature (T) was monitored and maintained between 35.5ºC and 37.5ºC with a compressor-heater system.
The right internal jugular vein was dissected and cannulated with a 24 GA venocath; rats received 5 mL/kg/h of a lactated Ringer solution for replacement of negligible losses 12, 13 .
Immediately after the catheterization, G2 received intravenous glibenclamide (Glyburide â -Sygma, 0.1%), 1μg/g. The left carotid artery was dissected and cannulated with a 24 GA venocath to monitor the mean arterial pressure (MAP) using the Datex Engstron recording device (Finland).
Sixty minutes after glibenclamide administration in G2
and the corresponding time in G1, the animals from both groups underwent 30% blood volume loss through the carotid artery, which was performed in three time points with ten minutes of interval. At each time point, 10% of the total blood volume was withdrawn. Total blood volume was calculated as 6% of the body weight 14 . The arterial blood collected was used for laboratory analysis serum TNF-α and IL-1 cytokines.
After the last hemorrhage time point, the rats remained anesthetized for another 30 minutes, a bilateral nephrectomy was conducted, and the animals were euthanized with appropriate dose of sodium pentobarbital. Both kidneys removed were immediately sectioned along the longest axis and stored for immunohistochemical analysis in a Dubosque-Brazil solution (120 mL formaldehyde, 30 mL acetic acid and 2 g picric acid), for a minimum of 12 hours and a maximum of 36 hours; they were then transferred to 70% ethanol. Finally, coded numbers identified the kidneys.
In order to perform histologic study, slices with fragments from both kidneys were prepared by fixing in paraffin and then staining with hematoxylin/eosin (HE). Histology was evaluated and based on the following criteria: tubular dilation and necrosis. The Profile analysis of serum cytokines levels over time (T1 and T2) was conducted with tests to determine: 1) interaction between groups and time points, to verify similarity throughout the periods between both groups; 2) parity between both groups at all time points (the difference between both profiles) in the case of similarity acceptance; 3) the difference between time points in all the groups in the case of similarity acceptance; 4) the difference between groups at each time point; 5) the difference between time points within each group. F and p statistics were calculated in each tested hypothesis. Histological scores (0-3) in each kidney and comparison between the two groups were analyzed by the non-parametric Mann-Whitney test for independent groups. The differences were considered significant for p-values < 0.05.
Results
The animal weights (g) did not differ between G1 and G2, and were, respectively, 346 ± 81 and 338 ± 62. In G1, initial (T1) serum levels of TNF-α (pg/mL) were higher than normal (178.6 ± 33.5). Fifty minutes later (T2), these values had increased to 509.2 ± 118.8 (p<0.05); in G2, TNF-α serum levels were 486.2 ± 83.6 (T1) decreasing to 261.8 ± 79.5 (T2) (p<0.05) ( Table 1 ). In T1, G1<G2, and in T2, G1>G2 (p<0.05). Initial serum levels of IL-1 (pg/mL) (T1) in G1 were discretely lower than normal (148.8 ± 31.3), but increased significantly in T2 (322.6 ± 115.4) (p<0.05).
In G2, serum levels of IL-1 were 347.0 ± 72.0, in T1 and decreased to 327.3 ± 90.9, in T2 (Table 1 ). In T1, G1<G2 (p<0.05).
TABLE 1 -Mean ± standard deviation of TNF-α and IL-1 serum cytokine (pg/mL) levels, according to time points (T1 and T2) and groups (G1 and G2, each one with 10 rats submitted to hemorrhage of 30% of total blood volume, and G2 also to glibenclamide). IL-1 serum  Groups  T1  T2  T1  T2  G1 178.6 ± 33. Profile analysis p < 0.05 * difference between T1 and T2; # difference between G1 and G2; T1 = time point control and coincident with the first hemorrhage period (10% of total blood volume); T2 = time point which occurred 30min from the third and last hemorrhage period (10% of total blood volume) and immediately before the euthanasia of each animal.
TNF-α serum
Renal expression of TNF-α in tubular cells (Table 2 , Figure 1 ) showed 12 kidneys in G1 with staining percentages of up to 25% (p=0.03). In G2, 7/20 kidneys presented staining percentages from 76% to 100% (p=0.03), a result that was significant comparing to the remaining 13. There was no significant difference between renal expressions of TNF-α in tubular cells of both groups. Renal tubular cells expression of IL-1 ( Table 2 , Figure  1 ), in G1, was not present in six kidneys while five presented staining of up to 25%, four staining from 26% to 50% and five organs presented staining from 51% to 75%, but these differences were not significant. No kidney staining from 76% to 100% was observed in this group. In G2, seven kidneys, out of the total 20, presented staining from 76% to 100%, six from 51% to 75%, and five of up to 25%. Although no significance was found in the different intensities of the stainings observed, these were greater than the staining from 26% to 50% that was found in the two remaining kidneys of G2. No kidney was found without staining (p=0.03) in this group. Renal expression of IL-1 in both groups differed significantly: in G1, six kidneys had no staining, whereas in G2 no organ presented this result; in G2, seven kidneys had 76% to 100% of staining, while no kidney from G1 presented such level.
The study of IL-1 expression in the glomerular cells of G1 (Table 3 , Figure 1 ) showed three kidneys without staining, six kidneys with staining up to 25%, three with staining from 26% to 50 %, while two kidneys had staining from 51% to 75% and six from 76% to 100%. Also, there was no significant difference among the four kidneys, out of the total 20, of G2, which presented staining from 76% to 100% and the nine with staining from 51% to 75%, the three from 26% to 50% and the four with up to 25% TNF-α glomerular cells expression in ten kidneys of G1 (Table 3, Figure 1 ) presented staining percentages of up to 25% (p=0.01), in G2, 10/20 kidneys presented staining percentages between 76% and 100% (p=0.01). The comparison between the groups showed that, in G1, there were more kidneys with staining percentages of up to 25%; G2 had a higher number of kidneys in the staining percentages from 76%-100%. These differences were significant. TABLE 3 -Distribution of kidneys from rats of G1 and G2 groups (10 rats and 20 kidneys each), both submitted to hemorrhage of 30% of total blood volume, and G2 also to glibenclamide, according to the percentage of glomerular cells staining for TNF-α and IL-1. staining. There was no significant difference between G1 and G2 in the IL-1 expressions found in the glomerular cells (p=0.08).
TNF-α
Tubular dilation and necrosis were observed in the renal cortical area 30 minutes after the hemorrhage of 30% of total blood volume in both G1 and G2 rats. All the animals of G1 presented tubular dilation that was discrete in two animals, moderate in seven and intense in one. In G2, tubular dilation was not seen in two animals and was discrete in eight (G1 > G2; p < 0.05).
Tubular necrosis was seen in animals of both G1 and G2. In G1, it was discrete in three, moderate in three, intense in two and it was absent in two. In G2, it was absent in six, discrete in one, moderate in two and intense in one (Figure 2) . 
Discussion
In many organs, ischemia/reperfusion period is associated with acute inflammation and release of proinflammatory cytokines, but the exact mediating role of these substances on organ injury is unclear 15, 16 . In this study, the ischemia that occurred in the kidney was likely due to hemorrhaging without total loss of blood flow. Organ reperfusion occurred either through the external replacement of fluids that was provided or through an intrinsic self-preserving mechanism of the organ.
Sevoflurane inhibits the production of TNF-α 20,21 , resulting in protection against myocardial ischemia and reperfusion injury 22 . According to Kawamura et al. 23 , the balance between pro and antiinflammatory cytokine production may be one of the most important protective mechanisms determined by sevoflurane on myocardium. Renal protection by sevoflurane is still controversial, mainly because of the lack of uniformity in the research models used in the different studies 24, 25 .
In our study, TNF-α serum levels were already elevated in T1. Surgical stress for establishing the research model may have led to the slight elevation of cytokine levels found in G1, and the addition of glibenclamide, to the significant elevation in G2.
The hemorrhage caused in the animals at T2 may have stimulated TNF-α release, for the levels of this cytokine appear very elevated in G1. In G2, the increased TNF-α levels in T2 were less important than in T1 and also lower than in G1, although the concentration of the cytokine was twice the normal values. Inhibition of TNF-α production seen in T2 may have occurred in G2 as a preventive mechanism of overall inflammation, since TNF-α receptors are found in practically all organ cells. It is known that TNF-α induces the formation of soluble receptors in blood circulation [26] [27] [28] , which may act as natural inhibitors of that cytokine. If this is true, this same protective mechanism was to be seen later in G1, had the time of observation been longer, because the important elevation of TNF-α levels had only occurred between T1 and T2 in this group.
Renal TNF-α immunoexpression was more homogenous in G2 because all the cells were stained, and many large areas with very strong staining were seen. On the contrary, the distribution of TNF-α staining in G1 was not homogenous, and the largest part of the kidneys showed weak staining, with unstained areas being observed. Glibenclamide, in addition to inducing TNF-α serum formation, also induces the expression of TNF-α renal receptors.
Therefore, in G2, all the TNF-α produced was taken by tubular and glomerular receptors. It is worth mentioning that glibenclamide
Serum concentrations and renal expressions of IL-1 and TNF-a early after hemorrhage in rats under the effect of glibenclamide
behaved as a proinflammatory agent, playing a supporting role to TNF-α. However, a study in rats observed that glibenclamide reduced Central Nervous System (CNS) inflammation after subarachnoid hemorrhage, which indicates a positive action of this drug against the proinflammatory effects of cytokines, such as TNF-α
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.
In patients with type-2 diabetes mellitus, glibenclamide administration inhibits increased monocyte adhesion to endothelial cells, thus decreasing TNF-α production by these cells 30 . In mice, glibenclamide did not have an effect on the production of TNF-α and had very little effect on the activity of this cytokine, according to Fukuzawa et al.
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. Jiang et al. 32 found TNF-α as the first cytokine to appear after hemorrhage shock in rat tissue, followed by IL-1β.
A study on the role of TNF-α in renal dysfunction of rats that suffered 16.5% blood volume loss, without fluid resuscitation, used a compound that antagonized an intracellular In the glomerular cells, a significant difference in IL-1 staining was not observed between the groups; all of the cells were stained, and the majority of kidneys studied had very strong staining. In tubular cells, IL-1 staining was greater in G2; all of the studied cells were stained as were the majority of the kidneys, which also had very strong staining.
There are soluble IL-1 receptors that also inhibit the action of this cytokine in a dose-dependent manner. However, immunomodulation through IL-1 receptors seems to be less important than those of TNF-α receptors, since the latest are found in a greater number of organ cells. The general effects of IL-1 are the same of TNF-α, although it does not cause tissue damage by itself and is not lethal, even in high concentrations 28 .
IL-1 and TNF-α action was found to be synergic in almost all the in vitro and in vivo models of local or systemic inflammation. When either of the cytokines is specifically blocked, the severity of inflammation decreases 28 . In this study, hemorrhage and glibenclamide were shown to induce elevations of IL-1 and TNF-α levels, both in rat serum and kidneys, and sevoflurane was a factor that may have reduced this increase. TNF-α is a cytokine that promotes vasodilatation and was already presented in high concentration, in T1, in the animals of G2. These animals had better perfusion and milder ischemia, because of hypotension. Otherwise, in G1, renal changes would have been worse had the rats not received sevoflurane. The histologic injuries seen in both groups -tubular dilation and necrosis -may be attributed to low perfusion conditions after hemorrhagic shock, according to Guedes et al. 35 ,
in a similar experimental model. Depending on the degree of the hypotensive insult, the kidney would manifest acute spasm of the preglomerular arterioles with acute tubular necrosis 36 . In our study, the two types of histologic injuries occurred in both groups, but were more intense in G1. These findings may suggest a protective role of glibenclamide against renal aggression, through vasodilatation induction resulting in a better tissue perfusion. Further studies are needed to demonstrate if glibenclamide does have a protective role against immunemodulated renal aggression.
Conclusions
Hemorrhage and glibenclamide elevated TNF-α and IL-1 concentrations in serum and kidneys. High levels of TNF-α already present before the hemorrhage in the glibenclamide group may have attenuated the damages found in the kidneys after the ischemia event.
